Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of Conference Call on the financial results (Standalone and Consolidated) for the quarter and half year ended 30th September, 2023.31-10-2023
31-10-2023
Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst/ Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201530-10-2023
Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio Recording of Conference Call on the financial results (Standalone and Consolidated) for the quarter and half year ended 30th September, 202330-10-2023
Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Monitoring Agency Report30-10-2023
Piramal Pharma surges 8% as company swings into profit in Q2
For the September quarter, Piramal Pharma's reported a profit after tax of Rs 5 crore against a loss of Rs 37 crore in the year-ago period30-10-2023
Piramal Pharma clocks 11 per cent revenue growth in second quarter
All three business segments contribute to growth in the quarter28-10-2023
Piramal Pharma Ltd - 543635 - Statement Of Deviation And Variation Under Regulation 32 Of SEBI LODR Regulations, 2015.
Statement of Deviation and Variation under Regulation 32 of SEBI LODR Regulations, 2015.27-10-2023
Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Investor Presentation
Press Release and Investor Presentation27-10-2023
Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release and Investor Presentation27-10-2023